ArticleBMC medicine2022

A cost-effectiveness analysis of capecitabine maintenance therapy versus routine follow-up for early-stage triple-negative breast cancer patients after standard treatment from a perspective of Chinese society.

Ji-Bin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.